$CRSP have to think if this keeps sliding that vertex may just buy them. Already own a decent chunk of Crspr shares so could probably get it for less than 15bil. The only thing that gives me pause to that idea is that vertex has been funding other gene editing companies like mammoth and paid 900mil for 10% of revenues for ctx001 so they may have what they want already.